When the old lies quit working, change the message! Marketing 101
CDC Rolls Out 'Wild To Mild' Flu Shot Campaign To Reach Vaccine-Hesitant
CDC Rolls Out 'Wild To Mild' Flu Shot Campaign To Reach Vaccine-Hesitant | ZeroHedge
“
With these respiratory viruses, flu included, the vaccines aren’t very good at preventing milder disease. They’re much better at preventing serious complications. And I think we have not been very clear in presenting that information,” Schaffner said. “We have to acknowledge that. We have to say ‘Yep, it won’t prevent that mild disease. But here’s the benefit.’”
This is similar to the marketing U.S. regulatory agencies used with COVID-19 vaccines. Americans were first told they would only need two doses of an mRNA COVID-19 vaccine or a single dose of the Johnson & Johnson shown to prevent COVID-19—and that getting vaccinated would protect their neighbor. After Americans started experiencing breakthrough infections,
U.S. health agencies admitted the shots did not prevent COVID-19 or transmission of the virus to others, and vaccine efficacy was redefined by whether the vaccine prevented hospitalizations and death.
Linda Wastila, professor and Parke-Davis chair of geriatric pharmacotherapy with a doctorate in health policy, told The Epoch Times in an email that she finds it interesting the CDC is now promoting flu vaccines as a means of preventing severe disease instead of the flu.
"I wonder if they will go and revise their language for all the other vaccines, the vast majority of which also fail to prevent infection," she added.
Years of Data Show Flu Shots Have Low Efficacy
CDC Promotes 3 Respiratory Virus Vaccines for Fall With No Safety Data
The new quadrivalent flu shot is just one of three vaccines coming down the CDC's pipeline this fall. The agency recommends bivalent COVID-19 vaccines—recently authorized by the U.S Food and Drug Administration (FDA)
without clinical data—flu shots for individuals 6 months of age and older, and the new respiratory syncytial virus (RSV) vaccine. The CDC has not provided any data showing it is safe to coadminister these vaccines to any group, including those who are immunocompromised and pregnant women.
“
My primary concern with the CDC’s promotion of the flu, COVID, and RSV vaccines is the absolute lack of data we have on their co-administration,” Ms. Wastila told The Epoch Times in an email.
“We have very little data on the new RSV vaccine and virtually nothing on the new approved and authorized COVID boosters—approved and authorized by FDA yesterday on manufacturing data versus studies in people—although Moderna did check for antibody responses in 100 subjects, which is insufficient.” Ms. Wastila said she’s also concerned about the broad acceptance of the idea that there is one flu vaccine or one COVID-19 vaccine when there are now three COVID-19 vaccines available on the market—new Pfizer and Moderna boosters and Novavax—and it is unknown how these vaccines interact with flu and RSV vaccines. “There is no study that looks at all three of these types of vaccines taken together,” she said. “I have grave concerns that the combination of all three will greatly impair recipients’ immune systems. In particular, the impacts of the live vaccine on immunity."